Summary
Alba Meira is a molecular biologist and postdoctoral fellow with eight years of experience dissecting the genetic and epigenetic drivers of cancer, currently based at the Bernstein Laboratory, Dana-Farber/Harvard and formerly at the University of Oxford. She applies cutting-edge single-cell genomics and epigenomics (scRNA-seq, scDNA-seq, ATAC-seq) alongside bespoke bioinformatic pipelines to characterize heterogeneity in leukemic stem cells driving myeloid leukemias. Alba has a strong track record in grant writing, supervising and training students, and translating complex wet-lab assays into analyzable NGS datasets. Her DPhil in Molecular Hematology and cross-institutional experience in the UK and US underpin a rigorous, hypothesis-driven approach aimed at uncovering how cancer evolves. Colleagues value her creative problem-solving and persistence in tackling technically challenging single-cell questions that bridge bench and computational biology.
8 years of coding experience
1 year of employment as a software developer
DPhil in Medical Sciences, Molecular Hematology, DPhil in Medical Sciences, Molecular Hematology at University of Oxford
Master of Research, Cancer Biology, Master of Research, Cancer Biology at Imperial College London
Bachelor of Science (BSc) Honors Biotechnology, Ciencias experimentales, Bachelor of Science (BSc) Honors Biotechnology, Ciencias experimentales at Universidad de Salamanca
English, French, Galician, Spanish